Breast Cancer Treatment Market Size, Share, Opportunities, And Trends By Type of Breast Cancer (Invasive, Non-Invasive (in situ)), By Diagnosis (Blood Tests, Mammogram, Breast MRI, Breast Ultrasound, Breast Biopsy, Others), By Treatment (Breast Cancer Surgery, Radiation Therapy, Chemotherapy, Hormone Therapy, Targeted Therapy, Supportive/ Palliative Care), And By Geography - Forecasts From 2025 to 2030

Breast Cancer Treatment Market Size:

The Breast Cancer Treatment Market is expected to grow from US$35.848 billion in 2025 to US$50.374 billion in 2030, at a CAGR of 7.04%.

The breast cancer treatment market is expected to grow at a moderate pace during the forecast period due to the worldwide prevalence of breast cancer. The main reasons for the disease include the consumption of alcohol and greater birth weight. The growing adoption of unhealthy lifestyle conditions among women of different age groups is leading to higher incidences of cancer during the forecast period.

Breast cancer survival rates vary greatly worldwide, ranging from 80% or more in the North American region, Sweden and Japan to around 60% in the middle-income countries and below 40% in low-income countries (Source: WHO). Growing awareness regarding self-care and self-management, technological advancements, and R&D expenditure is further driving the market growth during the forecast period. Currently, available treatment includes medications, therapy devices, and technologies in addition to palliative or supportive care. However, the high cost of treatment may restrain the market growth during the forecast period.

Major industry players profiled as part of the report are Novartis AG, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, AbbVie Inc., AstraZeneca, Orbital Therapy, Cianna Medical, Inc., IntraOp Medical Corporation, iCAD, Inc., and IceCure Medical, Inc.

Breast Cancer Treatment Market Scope:

Report Metric	Details
Breast Cancer Treatment Market Size in 2025	US$35.848 billion
Breast Cancer Treatment Market Size in 2030	US$50.374 billion
Growth Rate	CAGR of 7.04%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Type of Breast Cancer Diagnosis Treatment Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Breast Cancer Treatment Market	Novartis AG F. Hoffmann-La Roche Ltd Bristol-Myers Squibb AbbVie Inc. AstraZeneca
Customization Scope	Free report customization with purchase

 

The breast cancer treatment market is analyzed into the following segments:

• By Type of Breast Cancer

o Invasive
o Non-Invasive (in situ)

• By Diagnosis

o Blood Tests
o Mammogram
o Breast MRI
o Breast Ultrasound
o Breast Biopsy
o Others

• By Treatment

o Breast Cancer Surgery
o Radiation Therapy
o Chemotherapy
o ‘Hormone Therapy
o Targeted Therapy
o Supportive/ Palliative Care

• By Geography

o North America
o USA
o Canada
o Mexico
o Others
o South America
o Brazil
o Argentina
o Others
o Europe
o Germany
o France
o United Kingdom
o Spain
o Others
o Middle East and Africa
o Saudi Arabia
o Israel
o Others
o Asia Pacific
o China
o Japan
o South Korea
o India
o Others

---

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. KEY FINDINGS
4. MARKET DYNAMICS
4.1. Market Overview and Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Prevalence
4.5.1. By age group
4.5.2. By region
4.6. Product Pipeline
4.7. Innovations
5. BREAST CANCER TREATMENT MARKET BY TYPE OF BREAST CANCER
5.1. Invasive
5.2. Non-Invasive (in situ)
6. BREAST CANCER TREATMENT MARKET BY DIAGNOSIS
6.1. Blood Tests
6.2. Mammogram
6.3. Breast MRI
6.4. Breast Ultrasound
6.5. Breast Biopsy
6.6. Others
7. BREAST CANCER TREATMENT MARKET BY TREATMENT
7.1. Breast Cancer Surgery
7.2. Radiation Therapy
7.3. Chemotherapy
7.4. Hormone Therapy
7.5. Targeted Therapy
7.6. Supportive/ Palliative Care
8. BREAST CANCER TREATMENT MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentia
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. Israel
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. South Korea
8.5.4. India
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Novartis AG
10.2. F. Hoffmann-La Roche Ltd
10.3. Bristol-Myers Squibb 10.3.1. Overview
10.4. AbbVie Inc.
10.5. AstraZeneca
10.6. Orbital Therapy
10.7. Cianna Medical, Inc.
10.8. IntraOp Medical Corporation
10.9. iCAD, Inc.
10.10. IceCure Medical, Inc.
LIST OF FIGURES
LIST OF TABLES

Novartis AG
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb
AbbVie Inc.

AstraZeneca
Orbital Therapy
Cianna Medical, Inc.
IntraOp Medical Corporation
iCAD, Inc.
IceCure Medical, Inc.